青少年特发性脊柱侧凸女孩基线血清FSTL1肌因子较高可能作为支具治疗成功的潜在预测生物标志物
该回顾性病例对照研究纳入117例骨骼未成熟的青少年特发性脊柱侧凸女孩,在开具支具时检测8种肌因子基线血清浓度,随访至停用支具,以Cobb角进展>5°定义为失败。结论认为FSTL1可能作为预测支具治疗结局的生物标志物。
要点
- 失败组基线FSTL1均值显著低于成功组(2217.3±617.0 vs 1369.3±704.9,P=0.002)。
- 失败组初始Risser征及apelin、fractalkine、musclin基线水平均较低。
核心结论
- 支具治疗失败的青少年特发性脊柱侧凸患者基线FSTL1平均血清水平显著低于治疗成功者。
- FSTL1可能作为生物标志物用于提示支具治疗后的结局。
研究设计与样本
- 回顾性病例对照研究,纳入无支具或手术既往史的骨骼未成熟青少年特发性脊柱侧凸女性患者。
- 在开具支具时采集外周血,用多重检测法测定8种肌因子基线血清浓度。
- 随访至停用支具,Cobb角进展>5°定义为失败,其余为成功;采用逻辑回归分析校正血清肌因子与骨骼成熟度。
主要发现
- 共纳入117例患者,其中27例位于失败组。
- 失败组初始Risser征低于成功组。
- 失败组基线FSTL1为2217.3±617.0 vs 1369.3±704.9(P=0.002),apelin为116.5(12.0, 335.9)vs 83.5(10.5, 221.1)(P=0.016),fractalkine为979.6±457.8 vs 743.8±456.1(P=0.020),musclin为211.3(16.3, 370.3)vs 67.8(15.5, 325.6)(P=0.049)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: A retrospective case-control study. OBJECTIVE: This study aimed to investigate whether myokine, which is related to exercise and muscle mass, could serve as a biomarker for predicting bracing outcomes. SUMMARY OF BACKGROUND DATA: Several risk factors have been documented to be associated with bracing failure in patients with adolescent idiopathic scoliosis (AIS). However, serum biomarkers have not been extensively explored. PATIENTS AND METHODS: Skeletally immature females with AIS, without previous histories of bracing or surgery, were included. Peripheral blood was collected at the time of the bracing prescription. Baseline serum concentrations of 8 myokines [apelin, fractalkine, brain-derived neurotrophic factor, erythropoietin, osteonectin, fatty-acid-binding protein 3, follistatin-like 1 (FSTL1), and musclin] were measured by multiplex assays. Patients were followed up until weaned from bracing and then designated as a "failure" (defined as Cobb angle progression >5°) or "success." A logistic regression analysis was performed that accounted for serum myokines and skeletal maturity. RESULTS: We included 117 patients, with 27 in the failure group. Patients in the failure group had lower initial Risser sign and lower baseline serum levels of myokines, including FSTL1 (2217.3 ± 617.0 vs . 1369.3 ± 704.9, P = 0.002), apelin [116.5 (12.0, 335.9) vs . 83.5 (10.5, 221.1), P = 0.016], fractalkine (979.6 ± 457.8 vs . 743.8 ± 456.1, P = 0.020), and musclin [211.3 (16.3, 370.3) vs . 67.8 (15.5, 325.6), P = 0.049]. Following adjusted analysis, serum FSTL1 [odds ratio = 10.460; (2.213-49.453)] was determined to be predictive of bracing effectiveness. CONCLUSION: Patients who failed AIS bracing had significantly lower mean baseline levels of FSTL1 than those who achieved success. FSTL1 may serve as a biomarker that can inform outcomes after bracing.
引用
- Feng Z, Wu Z, Ma Y, et al. Higher Baseline Serum Myokine of FSTL1 May Serve as a Potential Predictive Biomarker for Successful Brace Treatment in Girls With Adolescent Idiopathic Scoliosis. Spine (Phila Pa 1976). 2023. PMID: 37339276. doi:10.1097/BRS.0000000000004751
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。